Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DDX41-associated susceptibility to myeloid neoplasms
Hideki Makishima, Teresa V. Bowman, Lucy A. Godley
Blood (2022) Vol. 141, Iss. 13, pp. 1544-1552
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The DNA Damage Response and Inflammation in Cancer
Vanessa Klapp, Beatriz Álvarez-Abril, Giuseppe Leuzzi, et al.
Cancer Discovery (2023) Vol. 13, Iss. 7, pp. 1521-1545
Open Access | Times Cited: 54
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants
Álex Bataller, Sanam Loghavi, Yoheved Gerstein, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 11, pp. 1780-1790
Closed Access | Times Cited: 26
Novel precision medicine approaches and treatment strategies in hematological malignancies
Richard Rosenquist, Elsa Bernard, Tom Erkers, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 413-436
Open Access | Times Cited: 16
Inherited blood cancer predisposition through altered transcription elongation
Jiawei Zhao, Liam D. Cato, Uma P. Arora, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 642-658.e19
Open Access | Times Cited: 6
Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene–Environment Interactions
César Cobaleda, Lucy A. Godley, Kim E. Nichols, et al.
Cancer Discovery (2024) Vol. 14, Iss. 3, pp. 396-405
Open Access | Times Cited: 5
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 652-652
Open Access | Times Cited: 4
Spliceosomal helicases DDX41/SACY-1 and PRP22/MOG-5 both contribute to proofreading against proximal 3′ splice site usage
Kenneth Osterhoudt, Orazio Bagno, Sol Katzman, et al.
RNA (2024) Vol. 30, Iss. 4, pp. 404-417
Open Access | Times Cited: 4
Myelodysplastic syndrome with dual germline RUNX1 and DDX41 variants: a rare genetic predisposition case
Virginia Bove, María Noel Spangenberg, Carolina Ottati, et al.
Familial Cancer (2025) Vol. 24, Iss. 1
Closed Access
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome
Yael Kusne, Talha Badar, Terra L. Lasho, et al.
British Journal of Haematology (2025)
Open Access
Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation
Yasuhiro Kambara, Daichi Sadato, Takashi Toya, et al.
Leukemia (2024) Vol. 38, Iss. 3, pp. 667-670
Closed Access | Times Cited: 2
A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms
Rami Abdulbaki, Sheeja T. Pullarkat
Current Oncology (2024) Vol. 31, Iss. 5, pp. 2353-2363
Open Access | Times Cited: 2
Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications
Lucy A. Godley, Courtney D. DiNardo, Kelly L. Bolton
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 2
Multifunctional role of DEAD-box helicase 41 in innate immunity, hematopoiesis and disease
Jing Ma, Susan R. Ross
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Genomic testing for germline predisposition to hematologic malignancies
Sang Mee Hwang
Blood Research (2024) Vol. 59, Iss. 1
Open Access | Times Cited: 1
Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines
Hirotaka Matsui, Makoto Hirata
International Journal of Hematology (2024) Vol. 119, Iss. 5, pp. 552-563
Closed Access | Times Cited: 1
Peripheral Blood and Bone Marrow Findings in Treatment-Naive Patients With Cytopenia(s)/Myeloid Neoplasms Harboring Both a Germline and a Somatic DDX41 Mutation
Frido K. Bruehl, Ismail Elbaz Younes, David Bosler, et al.
Applied immunohistochemistry & molecular morphology (2024) Vol. 32, Iss. 8, pp. 371-381
Closed Access | Times Cited: 1
Genetic Predisposition to Myelodysplastic Syndrome: Genetic Counseling and Transplant Implications
Yi Liu, Kathleen A. Calzone, Lisa J. McReynolds
Seminars in Hematology (2024)
Closed Access | Times Cited: 1
DDX41 dissolves G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell death
Honghao Bi, Kehan Ren, Pan Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy
Ananna Bhadra Arna, Hardikkumar Patel, Ravi Shankar Singh, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 3
Clinical considerations at the intersection of hematopoietic cell transplantation and hereditary hematopoietic malignancy
Timothy E. O’Connor, Reid Shaw, Rafael Madero‐Marroquin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
DDX41: here, there…and everywhere
Christopher R. Reilly, Andrew A. Lane
Blood (2023) Vol. 142, Iss. 14, pp. 1177-1178
Open Access | Times Cited: 2
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
(2023)
Open Access | Times Cited: 2
Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD)
Rashmi Kanagal‐Shamanna, Kristian T. Schafernak, Katherine R. Calvo
Seminars in Diagnostic Pathology (2023) Vol. 40, Iss. 6, pp. 443-456
Closed Access | Times Cited: 2
Pathogenic DDX41 variants, possible response predictors to low‐dose melphalan in hypo‐ and normocellular MDS and AML
O. Nyquist, Jakob Dalgaard, Signe Spetalen, et al.
British Journal of Haematology (2023) Vol. 204, Iss. 2, pp. 724-729
Open Access | Times Cited: 2
Nucleic acid-induced inflammation on hematopoietic stem cells
Giang To Vu, Valerie Awad, María Feliz Norberto, et al.
Experimental Hematology (2023) Vol. 131, pp. 104148-104148
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top